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ABSTRACT 
In present work, Ligand butanone thiosemicarbazone and their 11 complexes of the type ML2X2, ML2X’, where M = Cu(II), Cd(II), Co(II), Zn(II), Hg(II); L = 
butanone thiosemicarbazone; X = Cl, NO3 or CH3COO;    X’ = SO4 have been synthesized and characterized with the help of infra-red and ultra-violet 
spectroscopy. The spectral data revealed that the thiosemicarbazone act as bidentate ligand, making use of thionic sulphur and the azomethine nitrogen atom 
for  co-ordination  to  the  central  metal  atom.    All  the  compounds  have  been  screened  for  their  antibacterial  activity  against  Gram  positive  bacteria 
Staphylococcus aureus, Staphylococcus epidermidis and Gram negative bacteria Escherichia coli and Pseudomonas aeruginosa. Some of complexes exhibited 
appreciable activity. 
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INTRODUCTION 
Thiosemicarbazone is emerging moiety with wide spectrum 
of biological activity and having sound scope in research and 
developing  process  in  pharmaceutical  and  medicinal 
chemistry. 
Thiosemicarbazones are of considerable interest because of 
their chemistry and potentially beneficial biological activity, 
such as antibacterial1-5 , antifungal6, antiviral7, antiamoebic8, 
antimalarial  9,10  and  antitumor  activity11.  The  biological 
activities of thiosemicarbazones are considered to be due to 
their ability to form chelates with metals. Biological activities 
of metal complexes differ from those of either ligands or the 
metal ions, and increase and/or decreased biological activities 
are  reported  for  several  transition  metal  complexes. 
Thiosemicarbazone  are  versatile compounds; two structural 
isomers (E-, Z –form) are possible and they can co-ordinate 
to the metal either as a neutral ligand or as a deprotonated 
ligand through the NS atoms12,13. 
Thiosemicarbazone  have  been  frequently  employed  for  the 
quantitative determination of inorganic ion12.    
 
MATERIALS AND METHODS 
Material and measurements 
 All  the  chemicals  and  solvents  of  Sigma-
Aldrich/CDH/Rankem/Merck  were  AR  grade  and  used 
without  any  further  purification.    All  the  reaction  were 
monitored  by  TLC  using  methanol:chloroform  (9:1)  as 
solvent  system.  TLC  plates  were  prepared  by  spreading 
method. These are dried in air and then activated by heating 
in hot air oven at 110 °C for 20 minutes. Iodine chamber was 
used  for  visualization  of  TLC  spots.  Anhydrous  potassium 
carbonate  was  used  in  desiccater.  Melting  point  of  all 
synthesized  compounds  was  determined  in  open  glass 
capillaries  and  was  uncorrected.  Magnetic  susceptibility 
measurements were carried out in the polycrystalline state on 
a Vibrating Sample magnetometer. IR spectra were recorded 
by  making  KBr  pellets  on  Jasco  fourier  transform  IR 
spectrophotometer;  FT/IR-4100.  UV  spectra  were  recorded 
by making methanol solution on Systronic pc based double 
beam  spectrophotometer  2202.  All  the  synthesized 
compounds  were  screened  for  their  antibacterial  activity 
using agar diffusion method. 
Synthesis of ligand; 2-Butanone Thiosemicarbazone 
(C5H11N3S) 
Thiosemicarbazide (0.01mol, 0.91g) was dissolved in ethanol 
(approx.60ml)  by  refluxing  at  50°C in  250  ml  Rbf.  In  the 
refluxing solution, the butanone (0.1mol, 0.89ml) solution in 
ethanol (approx.30ml) was added. The reaction mixture was 
refluxed  for  four  hours  at  60°C.  The  volume  of  reaction 
mixture  was  reduced  and  then  cooled  on  ice  water.  The 
crystals of butanone thiosemicarbazone were precipitate out. 
The  crystals  were  recrystallized  by  ethanol.  Yield:  1.33g 
(92%); m.p.: 99°C; TLC: Rf: 0.91 (CHCl3:CH3OH, 9:1, v/v); 
IR: υmax/cm-1: table-.2; UV: λmax/nm: table-2. 
Synthesis  of  metal  complexes  of  Butanone 
Thiosemicarbazone 
Ethanol  solution  of  metal  salts  was  refluxed  with  ethanol 
solution of butanone thiosemicarbazone in 1׃2 ratio for 0.5-
1.0 hr. Volume of the resulting clear solution was reduced to 
10 ml by a rotary vacuum evaporator and the solution was 
left  overnight.  The  resulting  crystalline  compounds  were 
filtered  under  suction,  washed  with  ethanol  and  ether,  and 
dried in vacuum.   
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Table 1: Physical data of compounds 
Comp.  Mol. 
Formula 
Mol. 
Weight 
% 
Yield 
mp  µeff 
B.M. 
Soluble 
In 
Comp.1  C5H11N3S  145  92  99  -  Ethanol 
Chloro- form 
Comp.2  [Cu(C5H11N3S)2Cl2]  425  41  190  1.82  DMSO 
DMF 
Comp.3  [Cu(C5H11N3S)2(No3)2]  478  30  160  1.79  DMSO 
DMF 
Comp.4  [Cu(C5H11N3S)2SO4]  450  36  175  2.51  DMSO 
DMF 
Comp.5  [Cd(C5H11N3S)2SO4]  499  72  224  2.63  DMSO 
DMF 
Comp.6  [Co(C5H11N3S)2Cl2]  420  17  205  5.1  DMSO 
DMF 
Comp.7  [Co(C5H11N3S)2(No3)2]  473  20  215  4.8  DMSO 
DMF 
Comp.8  [Zn(C5H11N3S)2Cl2]  427  36  204  -  DMSO 
DMF 
Comp.9  [Zn(C5H11N3S)(No3)2]  480  39  218  -  DMSO 
DMF 
Comp.10  [Zn(C5H11N3S)2SO4]  452  76  240  -  DMSO 
DMF 
Comp.11  [Zn(C5H11N3S)2(CH3COO)2]  474  20  180  -  DMSO 
DMF 
Comp.12  [Hg(C5H11N3S)2SO4]  587  22  220  7.8  DMSO 
DMF 
 
Table 2: Infra-Red (cm
-1) and Ultra-Violet (λmax in nm) Spectrum Data of Compounds 
Comp.  υ(C=N)  υ(C=S)  λmax 
Comp.1  1595  774  268 
Comp.2  1592  764  241 
Comp.3  1559  744  244 
Comp.4  1566  698  227 
Comp.5  1572  737  265 
Comp.6  1563  698  269 
Comp.7  1575  740  241 
Comp.8  1535  761  270 
Comp.9  1576  741  268 
Comp.10  1501  708  270 
Comp.11  1577  743  282 
Comp.12  1545  682  232 
 
Table 3: Antibacterial activity of compounds (comp.1 to 12) and standard. Zone of inhibition in mm. 
Comp. 
 
Conc. of comp. 
per disc 
Gram Positive Bacteria  Gram Negative Bacteria 
S. aureus  S.epidermidis  E. coli  P.auriginosa 
Zone of inhibition in mm (mean of there replicates) 
Comp.1  30μg  4  2  2  3 
200μg  5  5  3  4 
Comp.2  30μg  6  8  10  8 
200μg  15  10  15  10 
Comp.3  30μg  7  8  8  7 
200μg  11  12  13  10 
Comp.4  30μg  2  2  3  3 
200μg  10  8  9  10 
Comp.5  30μg  5  4  5  3 
200μg  13  7  14  13 
Comp.6  30μg  3  1  1  2 
200μg  9  7  4  5 
Comp.7  30μg  3  1  2  5 
200μg  10  8  6  7 
Comp.8  30μg  5  4  6  2 
200μg  10  8  15  11 
Comp.9  30μg  3  2  2  2 
200μg  9  7  8  10 
Comp.10  30μg  2  2  2  2 
200μg  7  7  7  5 
Amikacin  30μg  19  20  21  25 
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RESULTS, DISCUTION AND CONCLUSION 
Physical Properties 
Complexes  reported  in  the  present  investigation  have  the 
general composition ML2X2 and ML2X’, where M = Cu(II), 
Cd(II),  Co(II),  Zn(II),  Hg(II);  L  =  butanone 
thiosemicarbazone; X = Cl or NO3 or CH3COO; X’ = SO4. 
These  are  crystalline  compounds.  All  the  complexes  have 
µeff  values  in  the  range  of  1.82  to  7.8  B.M  indicating 
presumably  a  spin-free  octahedral  or  distorted  octahedral 
configuration  of  these  compounds.  The  complexes  of 
copper(II)  are green, cadmium(II) are  cream, cobalt(II)  are 
dark  orange,  zinc(II)  are  white,  and  mercury(II)  are  black. 
(table-1), 
Infra-Red Spectra 
IR  spectra  of  compounds  provide  evidence  regarding  the 
bonding sites in the complexes The interest in the IR spectra 
of the bidentate nitrogen donar ligand lies mainly in the peaks 
due to (C=S) group and (C=N) group. The ligand may exist 
in  the  thione-thiol  tautomerization  since  they  contain  a 
thioamide  function  group.  However  due  to  absence  of  the 
υ(S-H)  stretching  in  the  region  2500-2600  cm-1  in  the  IR 
spectra of ligands indicate that the ligand retain their thione 
form  in  the  solid  state.  This  is  further  inferred  from  the 
presence of a peak at 774cm-1 due to the υ(C=S) stretching 
with some contribution of υ(C-N) 
υ(C=N) with some amount of contribution of δ(NH2) is found 
at 1595 cm-1  and a lowering in  frequency  of this  band on 
complex  formation  supports  the  co-ordination  through  the 
azomethine nitrogen. The υ(C=S) in the complexes shifted to 
lower frequency there by indicating the involvement of the 
thione  sulfur  in  complexes  formation.  Thus  ligand  has  NS 
donor bidentate nature in these complexes. (Table-2)  
Ultra-Violet spectra:- 
UV  spectra  of  ligand  and  complexes  were  recorded  in 
methanol. In UV spectra ligand shows λmax at 268 nm with a 
shoulder band. It indicate that in methanol solution the ligand 
exist in thiol form. After complexation λmax shifted to lower 
frequency/higher frequency depending upon the centre metal 
atom.  The  increase  in  intensity  is  attributed  to  extended 
conjugation in the ligand moiety after complexation. (Table 
2) 
Biological activity:-  
The synthesized compounds were tested for their antibacterial 
activity  by  measuring  the  inhibition  area  on  agar  plates 
(diffusimetric  method)  with  Gram  positive  bacteria 
Staphylococcus  aureus  MTCC  737,  Staphylococcus 
epidermidis  MTCC  3615  and  Gram  negative  bacteria 
Escherichia coli MTCC 1687, and Pseudomonas aureginosa 
MTCC  1687.  The  results  of  antibacterial  activity  of 
complexes  together  with  the  result  of  free  butanone 
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thiosemicarbazone as comparison are listed in table 3.3, as 
estimated by zone of inhibition (mm).     
The results show that free thiosemicarbazone (comp.1) does 
not have effective antimicrobial activity against selected test 
organisms,  while  complexes  Dichlorobis(2-butanone 
thiosemicarbazone)copper(II)  and  Sulphatobis(2-butanone 
thiosemicarbazone)mecury(II) (comp.2 to 12) have effec- tive 
antimicrobial  activity.  The  comp.2  posses  good  activity 
against one Gram positive bacteria (S. aureus) and one Gram 
negative bacteria (E. coli) while comp.12 show good activity 
against all the test organism. The complexes Dinitratobis(2-
butanone  thiosemicarbazone)copper(II),Sulphatobis(2-
butanone  thiosemicarbazone)copper(II),  Dichlorobis(2-
butanone  thiosemicarbazone)  zinc(II),    Diacetylobis(2-
butanone  thiosemicarbazone)zinc(II)  (comp.3,  4,  8,  11) 
posses moderate activity while remaining compounds show 
poor activity against test organisms 
 
CONCLUSION:- 
The  ligand,  butanone  thiosemicarbazone  and  their  metallic 
complexes were synthesized and characterized by the infra-
red and ultra-violet spectroscopic method. It is examined that 
in  these  comoplexes  the  ligand  has  NS  donor  bidentate 
nature. The biological behavior revealed that ligand shows a 
weak activity against the test bacterial strains. The chelation 
induced significant changes in the biological activity of the 
ligand.  Complexes  Dichlorobis(2-butanone 
thiosemicarbazone)copper(II)  and  Sulphatobis(2-buta-  none 
thiosemicarbazone)mecury(II)  (comp.2  and  12)  show  good 
activity against the selected test organisms. 
 
REFERENCES                                     
1.  Parekh  A.K.  and  Desai  K.K.,  ‘Synthesis  and  antibacterial  activity  of 
thiosemicarbazones’ Indian J. Chem.2006; 45B; 1072. 
2.  Chandra S. and Gupta L.K.,  ‘Spectroscopic and biological studies on 
newly  synthesized  nickel(II)  complexes  of  semicarbazone  and 
thiosemicarbazones’, Spectrochimica Acta Part A.2005;62;1089. 
3.  Demertzi  D.K.,  Miller  J.R.,  Kourkoumelis  N.,  Hadzikaaou  S.K.  and 
Demertzis M.A.‘Palladium(II) and Platinum(II) complexes of pyridine-
2-carbaldehyde  thiosemicarbazone  with  potential  biological  activity. 
Synthesis,  structure  and  spectral  Properties.  Extended  network  via 
hydrogen bond linkages of [Pd (PyTsc)Cl]’, Polyhedron1999;18;1005. 
4.  Ferrari B.M., Fava G.G. Leporti E., Pelosi G., Rossi R., Tarasconi P., 
Albertini  R.,  Bonati  A.,  Lunghi  P.  and  Pinelli  S.,  ‘Synthesis, 
characterization and biological activity of three copper (II) complexes 
with a modified nitrogenous base: 5-formyl uracil thiosemicarbazone’, J. 
Inorganic Biochem.1998; 70;145. 
5.  Ferrari M.B., Capacchi S., Reffo G., Aelosi G., Tarasconi P., Albertini 
R.,  Pinellis  S.,  Lunghi  p.,  ‘Synthesis,  structural  characterization  and 
biological activity of P-fluorobenzaldehyde thiosemicarbazones and of a 
nickel complexes’, J. of Inorg. Biochem.2000; 81; 89. 
6.  Bhat A.K., Bhamaria R.F., Patel M.R. Bellare R.A. and Deliwala C.V., 
‘Chemotherapy  of  fungus  infection  :  part  III  alkyl  or  aryl 
thiosemicarbazone, acid hydrazones, styryl aryl ketones of 5-bromo- and 
5-nitro-solicyaldehydes’, Indian J. chem.1972;10; 694. 
7.  Lobana  T.S.,  Rekha,  Butcher  R.J.,  Castineiras  A.,  Bermejo  E.  and 
Bharatam P.V., ‘Bonding trends of thiosemicarbazone in mono nuclear 
and di nuclear copper complexes : synthesis, structures and theoretical 
aspects’ Inorg. Chem.2006; 45; 1535. 
8.  Sharma  S.,  Athar  F.,  Maurya  M.R.,  Azam  A.,  ‘copper(II)  complexes 
with  substituted  thiosemicarbazone  of  thiophene  -2-carboxaldehyde  : 
synthesis,  characterization  and  antiamoebic  activity  against  E. 
histolytica’ European J. Med. Chem.2005; 40;1414. 
9.  Klayman D.L., Bartosevich J.F., Griffine T.S., Mason C.J. and Scovill 
J.P., ‘2-Acetylpyridine Thiosemicarbazones; 2-A New Class of Potential 
Antimalarial Agents’, J. Med. Chem.1979; 22; 854. 
10.  Klayman  D.L.,  Scovill  J.P.,  Bruce  J.  and  Bartosevich  J.,  ‘2-
Acetylpyridine  Thiosemicarbazones;  9-Derivative  of  2-Acetyl 
isoquinoline as potential antimalarial agents’ J. Med. Chem.1984; 27; 
84. 
11.  Liberta A. E. and West D.X., ‘Antifungal and Antitumour Activity of 
Hetrocyclic Thiosemicarbazones and their Metal Complexes’, BioMetal 
1992; 5; 121.  
12.  West D.X., Brain G.A., Jasinski J.P., Li Y., Pozdniakiv R.Y., Martinez 
J.  V.,  Toscano  R.A.  and  Ortega  S.  H.,  ‘Structural  studies  of  there 
isomeric  forms  of  hetrocyclic  N(4)-substituted thiosemicarbazone  and 
their two nickel complexes’, Polyhedron1996; 15;  665. 
13.  Kasuga  N.C.,  Sekino  K.,  Ishikawa  M.,  Honda  A.,  Yokoyama  M., 
Nakano  S.,  Shimada  N.,  Koumo  C.  and  Nomiya  K.,  ‘Synthesis, 
structural  characterization  and  antimicrobial  activities  of  12  zinc(II) 
complexes  with  four  thiosemicarbazone  and  two  semicarbazone 
ligands’, J. Inorg. Biochem.2003; 96; 298. 
 
 
 
 
Source of support: Nil, Conflict of interest: None Declared 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IRJP is an official publication of Moksha Publishing House. Website:  www.mokshaph.com. All rights reserved.  